Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
SMS Lifesciences India Ltd. ( (IN:SMSLIFE) ) just unveiled an announcement.
SMS Lifesciences India Ltd. has announced the closure of its trading window for designated and connected persons, effective from October 1, 2025, until 48 hours after the announcement of its financial results for the quarter and half-year ending September 30, 2025. This move is in compliance with SEBI’s regulations on insider trading and reflects the company’s adherence to governance standards, potentially impacting stakeholders by ensuring transparency and fairness in trading activities.
More about SMS Lifesciences India Ltd.
SMS Lifesciences India Ltd. operates in the pharmaceutical industry, focusing on the development and manufacturing of active pharmaceutical ingredients (APIs). The company is committed to delivering high-quality products and services, catering to both domestic and international markets.
Average Trading Volume: 364
Technical Sentiment Signal: Buy
Current Market Cap: 3.64B INR
See more data about SMSLIFE stock on TipRanks’ Stock Analysis page.